drugset / Trial / NCT03740737

Recombinant FSH Investigation in the Treatment of Infertility With Assisted Reproductive Technology (ART) (RITA-1)

NCT03740737

Phase 3 Completed 579 enrolled Ferring Pharmaceuticals
RandomizedParallel-groupQuadruple-blindTreatment

Summary

This trial investigates the effects of FE 999049 compared to placebo.

Timeline

Start
2018-10-26
Primary completion
2020-11-11
Completion
2020-11-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Follitropin delta Protein / enzyme biologic 12 ug Subcutaneous

Indications